Pilot data of PDiamond Lung Cancer Data

Asan Medical Center PDiamond - Data Access Policy

Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address jangsejin@amc.seoul.kr, along with the completed Data Access agreement below. DATA ACCESS AGREEMENT This Data Access Agreement ("Agreement") is entered into and made effective as of the Effective Date specified below by and between [Institution's Name] (hereinafter referred to as the "Data Recipient") and the Asan Medical Center (hereinafter referred to as "AMC"). This Agreement governs the terms and conditions under which the Data Recipient will access and utilize a de-identified dataset generated at AMC under the direction of Se Jin Jang, MD, Ph.D., entitled ‘Multidimensional Proteomics analysis of intractable cancers with prospective observational cohort for precision medicine’, dataset: PDiamond Korean Lung Cancer Data ("Data Set"). TERMS OF AGREEMENT 1. Responsibilities of AMC - AMC confirms that the Data Set was collected in accordance with applicable laws, regulations, and patient consent forms, and de-identified in compliance with the Bioethics and Safety Act, Republic of Korea. - AMC will ensure compliance with Institutional Review Board (IRB) approval for sharing the Data Set. 2. Responsibilities of the Data Recipient - The Data Recipient agrees to use the Data Set solely for the research project described in Section A - PROJECT DETAILS ("Study"). - Any additional uses of the Data Set must be subject to a separate agreement. - The Data Recipient shall comply with all applicable local, state, and federal regulations. - The Data Recipient must restrict access to the Data Set to the Principal Investigator and Other Users listed. - The Data Recipient agrees to notify AMC of any personnel changes within 30 days. - The Data Recipient shall not attempt to re-identify individuals in the Data Set. 3. Confidentiality - The Data Recipient agrees to disclose the Data Set only to personnel involved in the Study. - The Data Recipient must maintain secure handling of the Data Set to prevent unauthorized access. - Any breach of confidentiality must be reported to AMC within five (5) days. 4. Publication and Acknowledgment - The Data Recipient agrees to acknowledge AMC and its Principal Investigator in any publications or presentations resulting from the use of the Data Set. - Citations should reference the AMC Genomics Data Set as the source of the data. 5. Intellectual Property Ownership of any inventions or discoveries derived from the use of the Data Set will be governed by the Korean Patent Act, and AMC retains all rights to the Data Set. The Data Recipient shall not claim any intellectual property rights over the Data Set. 6. Data Protection Requirements Section A: Data Recipient Information This section must be thoroughly completed by the Data Recipient, providing detailed information about the institution, principal investigator, and any additional authorized personnel who will have access to the Data Set. The Data Recipient is required to ensure that all contact information is accurate and up-to-date for the purposes of this Agreement. - Data must remain encrypted and only decrypted when strictly necessary for the Study. - Upon completion of the Study, the Data Recipient must delete all decrypted files and any copies. - Any data transfer must be securely encrypted, and access through mobile or wireless networks is strictly prohibited unless authorized by AMC. 7. Liability and Indemnification - The Data Set is provided "as is" without any warranties, and AMC assumes no liability for damages arising from its use. - The Data Recipient agrees to indemnify and hold AMC harmless against any claims, damages, or liabilities arising from the misuse, mishandling, or unauthorized access of the Data Set, including any claims for intellectual property violations 8. Term and Termination - The Data Set is provided "as is" without any warranties, and AMC assumes no liability for damages arising from its use. - The Data Recipient agrees to indemnify and hold AMC harmless against any claims, damages, or liabilities arising from the misuse, mishandling, or unauthorized access of the Data Set, including any claims for intellectual property violations. 9. Agreement Signatures By signing below, both parties acknowledge that they have read and agree to the terms of this Data Access Agreement. The Data Recipient also agrees to be held fully responsible for any misuse or unauthorized access to the Data Set. The Data Recipient must complete Section A and the PROJECT DETAILS for the study's approval and monitoring. This information is crucial for proper evaluation. For any clarifications, contact AMC Principal Investigator, Dr. Se Jin Jang, as provided in Section B. Institution Representative: Date: _______________ Signature: ____________________________ Title: ________________________________ Principal Investigator: Date: _______________ Signature: ____________________________ Title: ________________________________ Section A: Data Recipient Information This section provides details of the Institution, Principal Investigator, and any co-investigators, staff, or students (collectively referred to as 'Other Users') who will be granted access to the Data Set. Effective Date [Insert Information] Institution Name [Insert Information] Institution Address [Insert Information] Principal Investigator [Insert Information] Title [Insert Information] Department [Insert Information] Email [Insert Information] Phone [Insert Information] Project Title [Insert Information] Other Users [Insert Information] PROJECT DETAILS (to be completed by the Requestor) *Project Summary (500 words max): *Data Set Analysis Plan ("Study"): *Introduction (Rationale and Background): *Research Aims: *Hypotheses: *Analytical Plan: *References: *EGA Study Accession Number *Dataset Accession Number Section B: AMC Principal Investigator Contact Information Name Se Jin Jang, MD, Ph.D. Title Professor of Pathology Address Department of Pathology, Asan Medical Center. 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea Tel +82-2-3010-5966 Email jangsejin@amc.seoul.kr